Pacgen Life Science Corporation announced earnings results for the full year ended March 31, 2019. For the full year, the company announced total revenue was CAD 460,362 compared to CAD 607,017 a year ago. Net loss was CAD 412,016 compared to CAD 283,315 a year ago. Basic loss per share was CAD 0.01 compared to CAD 0.01 a year ago.